This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Autonomic Dysfunction and Inflammation in Chronic Hemodialysis Patients

This study has been completed.
Information provided by (Responsible Party):
Matthias Girndt, Martin-Luther-Universität Halle-Wittenberg Identifier:
First received: April 7, 2009
Last updated: March 9, 2017
Last verified: March 2017
This study investigates the relationship between autonomic dysfunction and chronic inflammation in hemodialysis patients.

Autonomic Dysfunction Chronic Renal Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Autonomic Dysfunction and Inflammation in Chronic Hemodialysis Patients

Resource links provided by NLM:

Further study details as provided by Matthias Girndt, Martin-Luther-Universität Halle-Wittenberg:

Biospecimen Retention:   Samples Without DNA
Serum Samples will be frozen for later Cytokine Sampling.

Enrollment: 45
Study Start Date: April 2009
Study Completion Date: December 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Diabetic Dialysis Patients
Non-Diabetic Dialysis Patients
Healthy Controls


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Diabetic and Non-diabetic Dialysis Patients. Healthy Controls.

Inclusion Criteria:

  • Chronic Kidney Disease Stadium KDIGO 5D for at leat 3 months on Dialysis
  • Age >18 years
  • Sinus action in EKG
  • Patient capable for informed consent
  • Written and signed informed consent

Exclusion Criteria:

  • Clinical overt signs of infections of any kind
  • Active malign disease
  • CRP levels above 50 mg/L
  • Cardiac Pace Maker
  • Atrial Fibrillation
  • Refusal of informed consent
  • Cardiac Transplantation
  • Immunosuppressive medication
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00878033

Martin-Luther-Universität Halle-Wittenberg, Dept. of Internal Medicine II
Halle (Saale), Saxony-Anhalt, Germany, 06120
Sponsors and Collaborators
Martin-Luther-Universität Halle-Wittenberg
Principal Investigator: Matthias Girndt, M.D. University Hospital Halle, Dept. of Internal Medicine II
  More Information

Additional Information:
Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Matthias Girndt, Prof. Dr. med. habil. Matthias Girndt, Director, Martin-Luther-Universität Halle-Wittenberg, Dept. of Internal Medicine II, Martin-Luther-Universität Halle-Wittenberg Identifier: NCT00878033     History of Changes
Other Study ID Numbers: UKH-KIMII-001-09
Study First Received: April 7, 2009
Last Updated: March 9, 2017

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Failure, Chronic
Autonomic Nervous System Diseases
Primary Dysautonomias
Pathologic Processes
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic
Nervous System Diseases processed this record on September 20, 2017